ライフサイエンスコーパス: individualize

1 sing readmission rate will likely need to be individualized.

2 averaged reference this reference sample is individualized.

3 the timing of screening cessation should be individualized.

4 the cause of failure, and treatment must be individualized.

5 for immunosuppression needs to be carefully individualized.

6 developing and validating a model to predict individualized absolute risk reductions (ARR) of cardiov

7 tivity; the interval between visits then was individualized according to a strict prospective protoco

8 toms prior to development of LRTI), based on individualized action plans, over a 12- through 18-month

9 Individualized actions were taken in 23 of the 91 (25%)

10 The choice of regimens with DAAs should be individualized after thorough assessment for potential h

11 t recommendations could be improved by using individualized age- and sex-specific CVD risk thresholds

12 tacrolimus trough levels and the recipient's individualized alloimmune risk determined by HLA-DR/DQ e

13 We propose that individualized alterations in functional connectivity or

14 e excess deaths may be prevented by offering individualized and targeted interventions.

15 the HLA-I peptidomes were heterogeneous and individualized and were dominated by nonapeptides with s

16 We conclude that a patient-centered, individualized, and parsimonious approach to quality ass

17 tation efforts stand to gain from the use of individualized annotations that account for differences

18 hniques hold the potential for manufacturing individualized anthropomorphic phantoms in many clinical

19 pressure and provide a potential target for individualized antihypertensive therapies.

20 cies and clinical programs that encourage an individualized approach to glycemic control for U.S. adu

21 ntation of patient-centered care requires an individualized approach to hemodialysis vascular access,

22 asures and represents a clinical tool for an individualized approach to neurosensory restoration with

23 zing mechanistic subtypes of AF may guide an individualized approach to patient management.

24 clinical (phenotype) information for a more individualized approach to pharmacotherapy, to maximize

25 sease activity to enable a more targeted and individualized approach to pharmacotherapy.

26 We present an individualized approach to RCC surveillance that bases t

27 eomacular traction (VMT) and to recommend an individualized approach to treatment selection.

28 anagement paradigms and which necessitate an individualized approach to treatment.

29 rventional studies will have to confirm this individualized approach.

30 essment of perceived barriers may facilitate individualized approaches to implement exercise training

31 ts with chronic heart failure and help guide individualized, appropriate therapy-not all volume overl

32 Ten-year individualized ARR on major cardiovascular events by sta

33 ase III VISTA DME trial were maintained with individualized, as-needed treatment.

34 There is a need to individualize assays for tumor molecular phenotyping, gi

35 primary prevention with aspirin requires an individualized assessment of aspirin's effects on bleedi

36 Individualized assessment of hepatocellular carcinoma (H

37 opportunity to provide patients with a more individualized assessment of their risk of progressive l

38 older at high cardiovascular risk, based on individualized assessment, to achieve a target systolic

39 Individualized autoregulation-guided cerebral perfusion

40 decision regarding ligation intervals may be individualized based on patient and physician preference

41 roup received telephone and mailed outreach, individualized based on patients' cardiovascular disease

42 cision for the placement of mesh needs to be individualized based on the operative findings and the s

43 enge of how to implement this paradigm on an individualized basis.

44 in 20 one-hour group meetings with 30-minute individualized behavioral coaching sessions over 6 month

45 based approach (>/=7.5% 10-year risk) and an individualized benefit approach (ie, based on predicted

46 g injections (day 0 to month 2), followed by individualized best-corrected visual acuity (BCVA) and o

47 15, 28 women with uncomplicated pregnancies (individualized birthweight ratio [IBR] >20th percentile

48 To evaluate whether an individualized blood pressure management strategy tailor

49 death and treatment-related SAE to allow for individualized BP treatment goals based on each patient'

50 Whether these CVD risk thresholds should be individualized by age and sex has not been explored.

51 the cut-back technique, or group B using an individualized CAD/CAM zirconia abutment (CARES abutment

52 xic treatments can play an important role in individualized cancer medicine.

53 dentifying actionable alterations and making individualized cancer therapy (iCat) recommendations in

54 ediatric cancer, there is now enthusiasm for individualized cancer therapy based on genomic profiling

55 Individualized cancer treatment, tailored to a particula

56 enable accurate testing of drug response for individualized cancer treatment.

57 ROUND AND AIMS: Proteomics holds promise for individualizing cancer treatment.

58 rogeneous patient population is essential to individualize care and design future clinical trials.

59 the potential to improve decision making and individualize care.

60 l which includes the reciprocal path between individualized care and nursing care quality demonstrate

61 rsing care quality, trust, health status and individualized care remain obscure.

62 Data were collected in 2012-2013 with the Individualized Care Scale-Patient (ICS-Patient), the Onc

63 The recommendations highlight individualized care to manage the disease, prevent or de

64 Health status, individualized care, and nursing care quality were found

65 emselves to become more homelike emphasizing individualized care.

66 he use of biomarkers for the optimization of individualized care.

67 in nurses is influenced by the provision of individualized care.

68 nd trial designs offers a potential means of individualizing care to enhance outcomes for critically

69 on of PH subtypes is, therefore, crucial for individualizing care.

70 ides a virtual biopsy, sensitively revealing individualized changes in proteome-wide synthesis rates

71 ate and disentangle chromosomes, arriving at individualized chromatids with morphology observed in vi

72 omosomal DNA interactions, which compact and individualize chromosomes.

73 Individualized clinical assessment is of major importanc

74 he aim of the study was to determine whether individualized coaching improved surgical technical skil

75 then split tumors into subsets and developed individualized combinatorial treatments for two subtypes

76 their patients (n = 84) received a previsit individualized communication coaching session that incor

77 patients received question prompt lists and individualized communication coaching to identify issues

78 Oncologists received individualized communication training using standardized

79 rvention-group oncologists (n = 12) received individualized communication training; up to 10 of their

80 nt matching, cell dose, graft manipulation), individualized conditioning and serotherapy (eg, antithy

81 Individualized control decreased life expectancy (20.63

82 Results of Base-Case Analysis: Individualized control saved $13 547 per patient compare

83 To estimate the cost-effectiveness of individualized control versus uniform intensive control

84 Results of Sensitivity Analysis: Individualized control was cost-saving and generated mor

85 cids, total fat, and carbohydrate.We used an individualized controlled feeding study in which 153 pos

86 r disease and cancer is available to predict individualized conversion risks in newly ascertained cli

87 association between providing surgeons with individualized cost feedback and surgical supply costs i

88 igh-fiber (>/=18 g NSP/d) diets and received individualized counseling at the start of radiotherapy t

89 trial tested the noninferiority of a novel, individualized, cryotherapy-dosing strategy for each vei

90 We recommend individualized decision making for surveillance breast i

91 ening recommendations that emphasize shared, individualized decision-making and familiarity with CF-s

92 ing the risk of a next recurrence may inform individualized decision-making on surveillance frequency

93 The need for individualized definitions of pathogenic mechanisms befo

94 We describe our approach to building an Individualized Development Plan, the reasons we find the

95 hnologies has facilitated the development of individualized diagnostic evaluations and tailored treat

96 of MeCP2 mutations will enable improved and individualized diagnostics, and may lead to personalized

97 All participants will receive individualized dietary counseling sessions with a regist

98 Predictive biomarkers can play a key role in individualized disease monitoring.

99 This individualized disease-guided approach is simple and eas

100 Future studies could assess individualized dosing based on pharmacokinetic and pharm

101 ng VISTA DME were maintained and stable with individualized dosing during ENDURANCE, fluctuating by <

102 Individualized dosing of ATG to reach optimal exposure o

103 An individualized dosing regimen of ranibizumab 0.5 mg driv

104 She was in sixth grade with an individualized education program.

105 ect across a continuum of recurrence risk to individualize endocrine therapy decision making for prem

106 blood pressure, and retinopathy severity; an individualized estimate of the risk of retinopathy progr

107 All participants completed an individualized evidence-based behavioral intervention an

108 Access to individualized, evidence-based prognostic information is

109 The ability to individualize faces is a fundamental human brain functio

110 ion) and an intersession training period for individualized feedback and group discussion.

111 The optimal heart rate should be individualized for each patient, and total isovolumic ti

112 The final management decision should be individualized for specific patients depending on the pa

113 hearing-impaired (HI) listeners fitted with individualized frequency-dependent gain.

114 as examined for 154 HI listeners fitted with individualized frequency-specific gain.

115 dence-based medicine approach can be used to individualize glycemic goals and prevent overtreatment,

116 Individualized goal-directed hemodynamic resuscitation t

117 However, guidelines recommend individualizing goals on the basis of age, comorbidity,

118 hat we believe to be particularly useful for individualized health.

119 ierarchical models can inform the project of individualized health.

120 We refer to this endeavor as "individualized health." The present article comprises 2

121 ew, and possibly important consideration for individualized heart failure treatment.

122 e protein/100 mL of breast milk [n = 15]) or individualized high-protein supplementation based on pro

123 onor and patient factors with which to guide individualized immunosuppressant selections over time.

124 Less aggressive and more individualized immunosuppressive treatment and close cli

125 dividual patients to improve diagnostics and individualize immunotherapy.

126 n the ASC population that may allow for more individualized inferences and accelerate research toward

127 l concepts, such as decision making, and for individualizing instruction and feedback to each residen

128 using a sham-controlled crossover design at individualized intensity for 20 min and TMS was performe

129 Individualized interventions to reduce childhood exposur

130 BMI= 30-50 kg/m or HbA1C = 6.5-8.0% require individualized interventions to reduce surgical risk (gr

131 BMI= 30-50 kg/m or HbA1C = 6.5-8.0% require individualized interventions to reduce surgical risk (gr

132 In summary, a panel of individualized junctions derived from tumor DNA could be

133 Individualized language network mapping could be automat

134 bearing in mind that background genetics may individualize lesions and influence treatments.

135 Conclusion Individualized low-volume CM protocols based on automati

136 Purpose To prospectively develop individualized low-volume contrast media (CM) protocols

137 , selecting ever-smokers for screening using individualized lung cancer risk calculations may be more

138 Self-organizing artificial personalities individualize machine performance and identity through f

139 Individualized management of screen-detected adenocarcin

140 Individualized management strategy aimed at achieving a

141 dation for transitioning to more precise and individualized management.

142 ical process by a novel scoring scheme on an individualized manner.

143 Applying the individualized map to the large, predefined ONH sectors

144 improve the correlation; however, using the individualized map with the single 30 degrees ONH sector

145 eld locations and OCT without blood vessels, individualized map, and customized sector) and recompute

146 T and chose visual field locations using the individualized maps.

147 Groups received 3,200, 6,400, 9,600, or individualized maximum (IM) repetitions, during 1-hour s

148 ctigraphy) for 48 hours to accurately derive individualized mean awake and asleep BP.

149 ilation." Recent investigations suggest that individualized measurements of pulmonary mechanical vari

150 This could promote individualized mechanical ventilation by minimizing the

151 tests, suggesting that these can be used to individualize medical care.

152 ivity may add considerably to the toolbox of individualized medicine where decisions are based on ver

153 Precision (also known as personalized or individualized) medicine is frequently discussed today,

154 C < 7%) (P = 0.002) were used to develop the Individualized Metabolic Surgery (IMS) score using a nom

155 To better individualize metformin therapy and explore novel molecu

156 can achieve solutions containing exclusively individualized monolayers.

157 of a mobile clinical decision aid comparing individualized mortality risk estimates for dialysis ver

158 adjunct role to pharmacodynamically guide an individualized mTORi therapy.

159 meric parS sites, where it encircles DNA and individualizes newly replicated origins.

160 mmune surveillance may promote the design of individualized NK cell-targeted therapies to limit vascu

161 ary advice from nurses or doctors instead of individualized nutrition therapy (INT) that is provided

162 Behavioral intervention combined individualized nutritional counseling targeting increase

163 Together, these mechanisms generate a highly individualized olfactory sensory system by promoting neu

164 mplementation of skills), and psychological (individualized or group feedback and reflection) trainin

165 is a great deal of interest in personalized, individualized, or precision interventions for disease a

166 s demonstrated the value of these models for individualizing outcome predictions in high-risk patient

167 This finding should be considered for individualized parental approaches and decision making.

168 bject analysis was performed to evaluate the individualized pathological changes over time.

169 e insights to help use these measurements to individualize patient care beyond the current guidelines

170 approach to healthcare delivery that aims to individualize patient care by integrating data extracted

171 for other conditions to optimize health and individualize patient care.

172 t are also predictive of survival could help individualize patient therapies.

173 study, we hope to offer these patients more individualized patient care.

174 ess, treatment efficacy and the tailoring of individualized patient care.

175 ght to increase effectiveness and to provide individualized patient care.

176 ting overtreatment and promoting high-value, individualized patient-centered care.

177 prostatectomy, and provide comprehensive and individualized patient-centered interventions.

178 dification in AF ablation should move toward individualized patient-tailored ablation procedures.

179 Individualizing patient care is relevant, and in publish

180 actography map as a connectome blueprint for individualized, patient-specific, deterministic tractogr

181 tivity, but not inattention) on the basis of individualized patterns of abnormality.

182 Three distinct cardiac cell populations with individualized phenotypic properties consistent with car

183 tivational interviewing as a component of an individualized physical activity and lifestyle modificat

184 ine is integral to developing more effective individualized platforms for treating cancer patients.

185 discharge from the hospital is essential to individualize postdischarge plans.

186 r to transform these group-based findings to individualize prediction of patient outcomes.

187 resent article, on a risk calculator for the individualized prediction of a psychotic disorder in a 2

188 ng this score, a nomogram was built enabling individualized prediction of HCC occurrence at 1, 3, and

189 developed nomogram resulted in more accurate individualized predictions of the survival benefit from

190 This paper develops such an individualized predictor and illustrates the added value

191 ability is of great relevance for developing individualized prevention strategies and treatments for

192 udy of adult patients with VLS suggests that individualized preventive TCS regimens that achieve obje

193 Individualized profiling of ion channel gene expression

194 py progression in all zones without need for individualized programing.

195 The intervention was an individualized, progressive, task-specific upper-limb tr

196 entually facilitate the implementation of an individualized provision of preventive focused intervent

197 care Services (CMS) recently published their Individualized Quality Control Plan, which will be the o

198 in clinical practice by helping to tailor an individualized re-treatment interval in nAMD patients.

199 roach were similar to those reported for the individualized reactions, demonstrating the utility of t

200 atients that initiated MDR-TB treatment with individualized regimens between September 2000 and Novem

201 This online individualized risk calculator can be of clinical useful

202 nd externally validate a practical web-based individualized risk calculator tool for the transdiagnos

203 , intra-abdominal procedures to provide more individualized risk counseling and to better inform evid

204 Individualized risk of discharge to postacute care can b

205 Individualized risk prediction tools have an important r

206 with established phenotypic risk factors on individualized risk prediction.

207 l to drive personalized medicine by enabling individualized risk stratification and immunosuppression

208 he ICU now presents a unique opportunity for individualized risk stratification coupled with the inve

209 l be crucial to allow for the possibility of individualized risk-adapted therapy.

210 ty for recent genetic discoveries to improve individualized risk-benefit assessment for pharmacologic

211 fter which a nomogram was computed to assess individualized risk.

212 lp in adjusting standard treatment toward an individualized, risk-adapted therapy regime.

213 This technique may thus be useful for having individualized route maps for rapid evaluation of lympho

214 Our model for establishing an individualized schedule for retinopathy screening on the

215 The aim of this work was to develop an individualized score for predicting hepatocellular carci

216 l improve the use of genetic risk scores for individualized screening and prevention.

217 We propose that an individualized serology-based approach to MN, used to co

218 three colors, all chromosome pairs could be individualized simultaneously.

219 An individualized statin benefit approach can identify lowe

220 Individualized strategies are necessary to recognize and

221 y with TGFbeta neutralization offers a novel individualized strategy for vaccinating patients against

222 ion of sex-specific risk factors can improve individualized stroke risk assessment.

223 h current multimodality therapy including an individualized surgical treatment plan.

224 t therapeutic modification and discussion of individualized survivor care plans even at initial cance

225 exchange mechanism in ARDS is imperative for individualized symptomatic support of patients with ARDS

226 postoperative risk, management targeting an individualized systolic blood pressure, compared with st

227 Thus, selection of therapy is individualized, taking into account present and future m

228 sions on SSRI use during pregnancy should be individualized, taking into account the mother's psychia

229 nt, and 40 to 60 mg/day for GCA, followed by individualized tapering regimens in both diseases.

230 eactivity can provide a continuously updated individualized target for management of cerebral perfusi

231 irment, (f) universal access to evolving and individualized technologies, (g) biological intervention

232 e groups: The experimental group received an individualized telephone delivered lifestyle modificatio

233 t, uncorrected, corrected by fixed term, and individualized term, the declines were 47.0 (SD, 30.1),

234 F recommends that primary care professionals individualize the decision to offer or refer adults with

235 oblematic group behavior is therefore not to individualize the group but rather to change group norms

236 ti-obesity medications and best practices to individualize the selection process, and the use of test

237 study demonstrates that we can now begin to individualize the treatment of ILBC, with HER2, HER3, an

238 Lowering and individualizing the current amplitude in electroconvulsi

239 Individualizing the current amplitude reduced interindiv

240 This finding may have implications for individualizing the extent of surgical resection and rad

241 ormation on specific KRAS mutations may help individualize therapeutic and surveillance strategies fo

242 defined subtype of ASD and ID, suggesting an individualized therapeutic approach for PMS.

243 nd in vivo patient-specific tumor models for individualized therapeutic evaluation of cancers.

244 HH) will be essential for the development of individualized therapies and improved outcomes.

245 ally become drug targets for personalized or individualized therapies, can be easily tested.

246 from a treatment fitted to every patient to individualized therapies, taking into account the comple

247 , biomarker identification and the design of individualized therapies.

248 lessen the need for precision approaches to individualized therapies.

249 mise to addressing patient heterogeneity and individualized therapies.

250 tions suggest that a more robust approach to individualize therapy may enable greater frequency of po

251 l loss, illustrating how proteomic tools may individualize therapy.

252 The Individualized Therapy for Asthma in Toddlers study was

253 These data have important implications for individualized therapy for patients and clinical trials.

254 r response to chemoradiation, as a basis for individualized therapy of advanced esophageal cancer.

255 eatment efficacy, assisting in the design of individualized therapy.

256 ubsequent clinical trial design and promotes individualized therapy.

257 scuss the potential utility of MRD to direct individualized therapy.

258 nts at risk remains a challenge for adapting individualized therapy.

259 ular targets and develop specific agents for individualized therapy.

260 pulations and, consequently, will facilitate individualized therapy.

261 Conformal RT was individualized to a fixed risk of RILT (grade >2) and ad

262 about adopting MAT models of care should be individualized to address the unique milieu of each impl

263 Finally, all decisions should be individualized to each patient by not only recognizing s

264 ease, but clinical decision making should be individualized to specific patient circumstances.

265 cluding medical and surgical options, can be individualized to take into account the site, extent of

266 Decisions regarding management should be individualized to the institution, particularly when rec

267 s with a higher risk of complications and to individualize treatment decisions.

268 These biomarkers may help to individualize treatment in EAC patients.

269 These biomarkers may help to individualize treatment in EAC patients.

270 er case, it may aid in making more informed, individualized treatment decisions in daily practice by

271 Sixty-eight patients (46.3%) in the individualized treatment group and 92 (63.4%) in the sta

272 ete drug resistance profile would facilitate individualized treatment in place of empirical treatment

273 tment for cystic fibrosis (CF), yet optimal, individualized treatment of CF will require identificati

274 l prognostic factors and may facilitate more individualized treatment of these patients.

275 d suggest novel biological targets for early individualized treatment or prevention.

276 determine that risk and facilitate triage to individualized treatment pathways.

277 l for staging of thyroid cancer patients and individualized treatment planning.

278 ic biomarkers, hemoglobin A1c target ranges, individualized treatment plans, outpatient pharmacologic

279 anibizumab is critical for the assessment of individualized treatment regimens for neovascular age-re

280 linical trials, and presents suggestions for individualized treatment strategies for specific patient

281 the necessity for sex-specific research and individualized treatment strategies for the management o

282 n 56 of 147 patients (38.1%) assigned to the individualized treatment strategy vs 75 of 145 patients

283 seling session coupled with the provision of individualized treatment summaries and survivorship care

284 nd lead to the development of more effective individualized treatment.

285 of subtypes of diabetes that will facilitate individualized treatment.

286 d recognized that they were receiving highly individualized treatment.

287 abetic macular edema (DME) are important for individualizing treatment and optimizing outcome.

288 by a multidisciplinary team with the goal of individualizing treatment for patients.

289 in loss in schizophrenia, but also assist in individualizing treatment.

290 s that these therapies will require targeted individualized treatments based on identifying subjects

291 ty, and validated our approach of developing individualized treatments in mice with PDX tumors.

292 cepts in nuclear medicine for optimizing and individualizing treatments for many cancer entities.

293 Individualized tumor-specific primer panels of aberrant

294 lish the appropriate frequency and dosing of individualized turning protocols to prevent pressure inj

295 y and safety profile of PRN dosing driven by individualized VA stabilization criteria using ranibizum

296 Ranibizumab with an individualized VA-based regimen, with or without laser,

297 Individualized versus uniform intensive glycemic control

298 re nata (PRN) with or without laser using an individualized visual acuity (VA) stabilization criteria

299 Precision medicine using individualized VTE risk stratification helps ensure that

300 SUMMARY OF BACKGROUND DATA: Individualized VTE risk stratification may identify high